Netherlands-based ScreenPoint Medical is an AI technology company that develops Deep Learning and image analysis technology for automated reading of mammograms. The company’s software is used to improve early detection of breast cancer.
ScreenPoint raises Series C round
In a recent development, the company announced that it has raised $28M (approx €23.58M) in its Series C round of funding. The round was led by New York-based global venture capital and private equity firm, Insight Partners. In addition, existing investors including ScreenPoint Medical’s founders, Siemens Healthineers, and Oost NL, also invested in this round.